0001412408-26-000084
SEC filingPhreesia reported strong Q4 FY2026 results with record profitability and free cash flow, but significantly lowered its FY2027 revenue outlook due to reduced visibility in network solutions spending commitments.
Phreesia concluded fiscal 2026 with significant operational and financial achievements, marking a pivotal year in its evolution toward profitability. For the fourth quarter, the company reported revenue of $127.1 million, a 16% increase year-over-year, driven largely by the AccessOne acquisition in payment solutions. Excluding this acquisition, organic revenue growth was 7%. Profitability metrics showed substantial improvement, with Adjusted EBITDA reaching $29.4 million (23% margin) compared to $16.4 million in the prior year period. The company highlighted crossing $100 million in annual Adjusted EBITDA and generating over $50 million in free cash flow for the full fiscal year, alongside achieving positive GAAP net income for the first time as a public company.
Management addressed a notable shift in its forward outlook, specifically citing reduced visibility into spending commitments from pharmaceutical manufacturers in its network solutions segment. Consequently, the company lowered its fiscal 2027 revenue guidance to a range of $510 million to $520 million, down from the prior estimate of $545 million to $559 million. Management clarified that this adjustment reflects external market dynamics rather than a structural shift in demand or competitive positioning. Despite the revenue reduction, Phreesia maintained its Adjusted EBITDA guidance of $125 million to $135 million, underscoring the operating leverage and efficiency gains achieved through AI adoption and reduced reliance on outsourced resources.
Financially, the company strengthened its balance sheet by refinancing its Bridge Loan with a new five-year, $275 million senior secured revolving credit facility with Capital One, maturing in March 2031. This refinancing provides increased flexibility for capital allocation, including potential debt paydown, growth investments, and share repurchases. The company also noted the launch of ProviderConnect, expanding its marketing solutions to healthcare providers, which complements its existing PatientConnect offering.